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Several pulmonary diseases have a progressive 
course that can ultimately destroy the lung 
parenchyma, a condition known as a destroyed 
lung. Patients with destroyed lungs usually 
present with a long history of respiratory 
symptoms associated with significantly abnormal 
imaging studies [1]. Pneumonectomy was 
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Abstract 
Background: Pneumonectomy can be used to manage destroyed lung; however, it 
is associated with a high risk of complications. This study analyzed the outcomes of 
pneumonectomy in patients with destroyed lungs. 
Methods: The study included 28 patients who had pneumonectomy for benign lung 
diseases from January 2011 to December 2017. Descriptive analysis was used to 
present patients' demographics, surgical details, and postoperative outcomes. 
Intraoperative blood loss was compared in tuberculous vs. non-tuberculous patients 
and those who had extrapleural vs. intrapleural pneumonectomy. 
Results: The study included 11 (39%) males, and the mean age was 36.6 ± 9.8 years 
(range: 5– 61). The persistent cough was the presenting symptom in 93% of cases, 
expectoration in 78.6%, hemoptysis in 46.4%, and chest pain in 28.6% of patients. 
Indications for pneumonectomy were tuberculosis in 13 (46.4%), septic 
bronchiectasis in 10 (35.7%), invasive opportunistic infections in 3 (10.7%), 
neglected endobronchial foreign body in 1 (3.6%), and neglected rupture bronchus 
in 1 (3.6%) patient. Pneumonectomy was left-sided in 21 (75%) patients. We 
performed extrapleural pneumonectomy in 7 (25%) patients, intra-pericardial 
isolation in 5 (17.9%) patients, and two patients (7.2%) had completion 
pneumonectomy. Mean perioperative bleeding was 390.7± 233.8 ml. The 
intraoperative blood loss was more in patients with tuberculosis and extrapleural 
pneumonectomy (P< 0.05). Postoperative complications occurred in 7 patients 
(25%), and we reported one operative mortality.   
Conclusion: Pneumonectomy for benign lung disease is a challenging procedure. 
Destroyed lung due to TB and bronchiectasis are the most common indications. The 
outcome could be improved with careful patient selection, appropriate preoperative 












proposed as a treatment option for patients with 
destroyed lung [2]. It became the main treatment 
line for benign and destroyed lung diseases such 
as tuberculosis, bronchiectasis, and suppurative 
lung disease [3-5]. Pneumonectomy is associated 
with several complications and should be 
performed in carefully selected patients [6-8]. 
However, many surgeons believe that 
pneumonectomy for benign lung diseases can be 
performed with acceptable morbidity and 
mortality [3, 9, 10]. 
We aimed to describe the preoperative 
preparation, surgical techniques, and outcomes of 
pneumonectomy for patients with benign 
destroyed lungs. 
Patients and Methods: 
Design: 
This research is a retrospective study that 
included all patients who underwent elective 
pneumonectomy for benign lung diseases 
between January 2011 and December 2017.  After 
approval of the Medical Ethics Committee of the 
University (Reference number: SU-MR-179-2019), 
the medical files and records of those patients 
were reviewed and analyzed.  
Data 
Data collected for each patient included 
preoperative, operative, and postoperative 
variables. The preoperative data included 
patients' demographics, symptoms, etiology, and 
site of the lung disease, comorbidities, 
preoperative respiratory function tests, full 
preoperative hematological, microbiological, and 
biochemical laboratory tests. 
The decision of pneumonectomy was made 
based on the following criteria; radiological 
findings on the high-resolution computed 
tomography (CT) chest scan (Figure 1), the 
presence of symptoms of chronic pulmonary 
infection, history of frequent hospitalization, 
reduced daily activity, and low quality of life 
assessed with a Questionnaire Assessing the 
Quality of Life of Patients with Chronic Respiratory 
Diseases by Jacobs and colleagues [11]. 
In addition to the radiological findings and 
clinical symptoms of destroyed lung, the 
contralateral lung must be healthy without 
systemic severe medical illness. The CT findings in 
patients with destroyed lung were decreased 
volume of the affected lung with or without 
residual cystic bronchiectasis, herniation of the 
contralateral healthy lung, a decrease in the 
diameter of the pulmonary vessels of the affected 
lung, and hypertrophy of the ribs of the affected 
side. 
All patients with destroyed lung, either with a 
definite history of tuberculosis (TB) or not, were 
subjected to complete microbiological workup to 
exclude the presence of active TB before surgery. 
Positive detection of TB in sputum or bronchial 
lavage was considered a contraindication for 
surgery. The patient started on anti-TB therapy, 
and we postponed the operation for six months. 
We assessed the preoperative respiratory 
functions either with spirometry, room air arterial 
blood gas analysis, 6-minutes walk test (6-MWT), 
stairs climbing test, or ventilation/perfusion (V/Q) 
lung scan.
Figure 1: CT chest (axial and coronal views) shows destroyed left lung due to bronchiectasis





Figure 2: Pneumonectomy specimens; A: TB destroyed lung, B: bronchiectasis destroyed lung
In adult patients with a destroyed lung, if the 
preoperative FEV1 was less than 1.8L, the decision 
for pneumonectomy was made based on the V/Q 
lung scan and diffusion capacity of the lung for 
carbon monoxide (DLCO), which detected the 
respiratory capacity of the affected lung. 
We evaluated children younger than 12 years 
with 6MWT. Arterial oxygen saturation (SO2) was 
assessed by finger pulse oximetry before and after 
the test. All the children could walk continually for 
6 minutes, and none of them showed oxygen 
saturation lower than 93%.   
We performed a cardiac assessment for each 
patient with transthoracic echocardiography (TTE) 
and electrocardiogram (ECG). Mild to moderate 
pulmonary hypertension was detected in 4 cases 
during routine preoperative echocardiography.  
Bronchoscopy was performed to clean the 
tracheobronchial tree from secretions and rule 
out intrabronchial disease and neglected foreign 
bodies. Bronchoscopy was valuable in confirming 
the diagnosis of a neglected FB, neglected rupture 
bronchus. Three cases were TB positive in 
bronchoscopic lavage despite negative sputum. 
Sputum smears were obtained from all 
patients either from expectoration or with a 
bronchoscope.  If microbial growth was detected 
in the culture, the patient was treated with 
antibiotics according to culture and sensitivity. In 
all patients, intensive chest physiotherapy and 
postural drainage were performed for 14 days 
before the scheduled surgery to improve the 
respiratory function. 
During the preoperative preparation period 
and in the postoperative period, patients were 
subjected to a special dietary program consisting 
of high energy and a rich protein diet with vitamin 
supplements. 
Anesthetic protocol and operative technique 
General anesthesia was used in all patients 
using fentanyl (2 ug/kg) plus propofol (2mg/kg) for 
induction and rocuronium (0.6 mg/kg) for 
intubation and muscle relaxation. Anesthesia was 
maintained using propofol (2mg/kg/hr.) and 
fentanyl infusions (2ug/kg/hr.). Before 
endotracheal intubation, the tracheobronchial 
tree was washed out of secretions by 
bronchoscopy to minimize intraoperative 
contamination. 
One lung ventilation was achieved using a 
double-lumen tube for adult patients and 
uninvent tube with bronchial blockers in children. 
We inserted the tube under fiberoptic 
bronchoscopy guidance in all cases to confirm 
tube placement. 
We performed a classic posterolateral 
thoracotomy through the fifth intercostal space. A 






narrow intercostal space to gain adequate 
exposure of the pleural cavity; a small segment (1 
cm) from the posterior part of the lower rib was 
resected in 17 cases.  
Classic intrapleural pneumonectomy was the 
routine procedure in most cases. Dissection was 
performed in the extrapleural plane if there were 
severe adhesions between the lung and pleura 
and empyema history. During extrapleural 
dissection, attention for hemostasis was essential 
to reduce blood loss. We performed intra-
pericardial control of the hilar vessels if there were 
dense fibrosis and adhesions at the hilum. 
The main bronchus was isolated and cut as 
short as possible. The bronchial stump was closed 
with either a bronchial stapler or hand-sewed by 
absorbable sutures; polyglactin (Vicryl; Ethicon, 
Edinburgh, UK). 
The bronchial stump was reinforced using a 
mediastinal pleura, or intercostal muscle pedicle 
as described by Abdallah and his colleagues [12]. 
No reinforcement was applied for stapled stumps. 
Before the chest closure, the bronchial stump was 
examined for air leak underwater, and the pleural 
space was copiously irrigated with povidone 
iodine-containing saline solution. 
A single chest tube (28–32F) was routinely 
placed to drain the pleural space underwater seal 
for 24–48 hours. All specimens were examined 
grossly (Figure 2) and sent for pathological 
examination. Operative details were collected and 
analyzed, including operative time, intraoperative 
blood loss, and intraoperative events. 
Postoperative care, complications, and follow up 
Patients were routinely extubated in the 
operating room. Postoperatively, patients were 
monitored in the intensive care unit (ICU) for 24 to 
48 hours. In the first 72 hours, postoperative 
analgesia was mainly through a paravertebral or 
epidural catheter, which was inserted in the 
operation room. 
We observed the patients for signs of the 
mediastinal shift. The chest tube was clamped 
intermittently to maintain mediastinal stability, 
and the tube was removed if the drainage volume 
was 250 ml (serous) or less within 24 hours. 
Postoperative follow-up was performed using 
chest -X-ray and Chest CT if required. We reported 
the postoperative morbidities and mortalities and 
length of hospital stay. 
Statistical analysis: 
The analysis was conducted using the SPSS 
(Version 20) statistical software for Windows (IBM 
Corporation, Armonk, NY, USA). Data were 
presented as mean values or range for continuous 
variables and as numbers and percentages for 
categorical variables. Continuous data were 
compared using the Mann-Whitney test, and the 
difference was considered significant if P-value 
was less than 0.05. 
Results 
The study included 28 patients; 11 (39%) of 
them were males.  The mean age at the time of 
operation was 36.6 ± 9.8 (range 5-61) years, and 
the mean duration of symptoms was 11.6 years 
(range 1– 15). Nineteen (67.9%) patients had a 
history of frequent hospital admission (Table 1). 
Spirometry was done for 26 patients. Obstructive 
patterns were observed in TB patients, while 
restrictive patterns were observed in patients with 
bronchiectasis.  
In 11 patients, the FEV1 was very low, which 
was not satisfactory for the decision of 
pneumonectomy. Therefore, V/Q scintigraphy 
was performed to detect the affected lung's 
contribution to perfusion; the result was 
significantly low (range 2.85– 5.75 %; mean 4.75 
%). 
Culture and sensitivity of sputum revealed 
Streptococcus pneumoniae, Klebsiella 
pneumoniae, Staphylococcus aureus, and 
Pseudomonas aeruginosa. 
Two out of the 13 patients who had 
tuberculosis had associated empyema. The 
empyema space was drained with two chest tubes 
(apical 22 Fr, basal 30 Fr). The intrathoracic space 
was washed with povidone-iodine and antibiotic 
solution (based on culture and sensitivity) twice  





Table 1: Preoperative patients' characteristics. 
Continuous data are presented as mean± SD (range) 
and categorical data as number (percentages) 
Variables (n= 28) 
Males 11 (39%) 
Age  36.6± 9.8 (5- 61) 
Symptoms  
Cough  26 (93%) 
Expectoration 22 (78.6%) 
Hemoptysis 13 (46.4%) 
Chest pain  8 (28.6%) 
Dyspnea 5 (17.9%) 
Preoperative spirometry (n= 26) 
FEV1 (L) 1.66 ± 0.07 
FEV1 (%) 59% (44–71) 
FVC (L/s) 1.71 ± 0.29 
FVC (%) 58% (47–65) 
Medical comorbidities 
Diabetes mellitus 3 (0.11%) 
Hypertension  4 (0.14 %) 
COPD 4 (0.14%) 
CKD on dialysis 1 (0.035%) 
Etiology 
Tuberculosis 13 (46.4 %) 
Bronchiectasis 10 (35.7%) 
Aspergillosis 3 (10.7%) 




COPD: chronic obstructive lung diseases; CKD: 
chronic kidney disease; FB: foreign body; FEV1: 
forced expiratory volume in 1 s, FVC: forced 
vital capacity 
daily. These patients underwent surgery when a 
sterile pleural space was achieved. (Table 2) 
We performed extrapleural pneumonectomy 
in 7 (25%) cases; 5 patients had extensive 
adhesions between the lung and pleura with 
resulting pleural fusion, and two patients had an 
associated history of chronic empyema. The 
control and division of the hilar vessels were 
performed intra-pericardially in 5 (17.9%) patients 
due to dense fibrosis and severe adhesions. 
We used a stapling device for bronchial stump 
closure in 17 (61%) patients and hand-sewn in 
11(39%) cases. We reinforced hand sewed 
bronchial stumps with mediastinal pleura in five, 
the pericardial fat pad in three, and intercostal 
muscle flap in three cases. The mean operative 
time was 176 min (range 105–315). The mean 
intraoperative blood loss was 785 (range 50 –
1550) ml.  
In one patient, we encountered difficulty 
releasing the lung from the diaphragm, so we 
performed a second thoracotomy in the 7th 
intercostal space from the same skin incision to 
release the diaphragmatic adhesions.  
In two patients, while extrapleural dissection 
was performed, the diaphragm was detached 
from its costal attachment while practicing a blunt 
separation of the parietal pleura from the chest 
wall. This event necessitates a second 
thoracotomy in the eighth intercostal space to fix 
the diaphragm. 
Postoperative complications were considered 
as those occurring within 30 days 
postoperatively. (Table 2).  
Table 2: Operative and postoperative data 
Variables (n= 28) 
Pneumonectomy side 
Left 21 (75%) 
Right 7 (25%) 
Procedure 
Intrapleural pneumonectomy 21 (75%) 
Extrapleural pneumonectomy  7 (25%) 
Intra-pericardial isolation of hilar 
vessels 
5 (17.9%) 
Completion pneumonectomy 2 (7.2%) 
Bronchial stump closure 
Stapler closure  17 (61%) 
Hand sewed 11 (39%) 
Postoperative complications (n= 7, 25%) 
Broncho-pleural fistula+ empyema  1 (3.6%) 
Atrial fibrillation  4 (14.3 
%) 
Atelectasis  3 (10.7%) 
Heart failure  2 (7.1%) 
Respiratory failure requiring 
reintubation 
1 (3.6 %) 
Pneumonia requiring reintubation 1 (3.6 %) 
Bleeding requiring re-exploration 1 (3.6 %) 
Wound infection 2 (7.2 %) 
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Post pneumonectomy empyema with 
bronchopleural fistula occurred in one patient. 
The patient had a history of preoperative 
empyema and diabetes mellitus. Microbiological 
workup of empyema revealed the presence of 
Staphylococcus aureus and was managed 
conservatively. 
We recorded on postoperative mortality in 63 
years old woman who had extrapleural left 
pneumonectomy for recurrent hemoptysis from a 
large left upper lobe mycetoma as a sequel of old 
pulmonary tuberculosis. The patient was weaned 
from the ventilator in the ICU on the same day. On 
the 4th postoperative day, the patient developed 
postoperative pneumonia and respiratory failure 
and died on the 16th day postoperatively.  
The effect of the technique of 
pneumonectomy and the associated tuberculosis 
on blood loss and operative time is presented in 
Table 3. 
The mean perioperative bleeding was 390.7 ± 
233.8 ml. The mean postoperative hospital length 
of stay was 11.3 (range 5 –39) days. In the early 
and late postoperative period, all the patients 
were evaluated and followed up by clinical and 
radiological examination.  The mean follow-up 
period was 32.3 ± 21.2 (range 9- 84) months. 
Discussion 
The destroyed lung is more prevalent in 
developing countries [13]. TB was the most 
common etiology of lung destruction in our study, 
followed by other chronic lung infections [1, 9]. 
Other rare causes include bronchial stenosis, 
pulmonary infarction, massive pulmonary trauma, 
Castleman's disease, and rare congenital 
abnormalities [3-5]. In other studies, the most 
common cause of destroyed lung was septic 
bronchiectasis, followed by tuberculosis [5, 13, 
14].  This difference may be related to the 
geographical location of the study. 
In our patients, bronchiectasis was mostly 
caused by recurrent exposure to pulmonary 
infections and inadequate medical treatment.  
Recent studies reported the same pathogenesis 
of bronchiectasis [5]. Several studies found that 
repeated pulmonary infections could lead to 
either enlargement of peribronchial lymph nodes 
or thickening of the bronchial lumen with 
subsequent obstruction [15]. Total lung 
bronchiectasis can result from neglected foreign 
body aspiration obstructing the main bronchus 
over long periods, as in one of our patients. 
Patients with a destroyed lung are at risk of 
developing fatal complications like massive 
hemoptysis, aspergillosis, septicemia, empyema, 
systemic-pulmonary shunting, and pulmonary 
hypertension [16]. It was found that 
pneumonectomy is the most rapid and effective 
method for preventing and treating such serious 
complications [9, 17]. 
According to previous studies, 
pneumonectomy is the main therapeutic tool that 
provides symptomatic relief and improves life 
quality despite all the operative difficulties and 
potential morbidities [4, 13, 18, 19]. However, 
some authors had emphasized the risk of 
pneumonectomy to manage destroyed lung 
disease [1, 20]. Therefore, careful patient 
selection is very imperative.  The ideal candidate 
for pneumonectomy should have symptomatic 




Figure 3: flow chart for management of patients with TB destroyed lung
normal contralateral lung, and absence of 
associated serious medical comorbidities. In our 
institution, we developed an algorithm for 
managing patients with destroyed lung (Figure 3); 
this algorithm was based on the predicted 
postoperative pulmonary function rather than the 
simple preoperative arbitrary numbers for FEV1 
values. Diffusion lung capacity for carbon 
monoxide (DLCO) helps us select the appropriate 
patients as this test considers the non-functioning 








In our patient series, the left lung was 
affected in 75% of the patients, similar to other 
series [5, 13]. This observation could be due to 
the more horizontal and narrower left bronchus; 
additionally, the left peri-bronchial space is limited 
by its relation to the aorta. It is more likely to be 
compressed by related enlarged lymph nodes [5]. 
The most important postoperative complications 
reported after pneumonectomy included 
bronchopleural fistula (BPF), empyema, 
reoperation for bleeding, contralateral 
pulmonary consolidation, and respiratory failure 
[14].  Published studies found that the presence 
of preoperative empyema, aspergillosis, massive 
blood loss, right pneumonectomy, reoperation for 
bleeding, and intraoperative dissemination were 
the most critical issues that lead to significant 
complications [21, 22]. 
It has been found that diabetes mellitus, liver 
dysfunction, nutritional deficiencies, and 
preoperative empyema were major risk factors for 
developing postoperative complications, 
especially BPF [13]. Odell and Henderson 
reported that the postoperative BPF occurred in 
more than 40% of patients with preoperative 
empyema [23]. Decrease sputum production by 
eradicating the underlying infections before 
surgery improves the nutritional status and 
decreases the risk of intraoperative spillage and 
reduces BPF and empyema. Additionally, using an 
appropriate closure technique for the bronchial 
stump and fixing it with adjacent tissues 
decreases the risk of BPF [5].   We agree with 
other reports [14], which stated that the 
bronchial stump management played a critical 
role in preventing the development of BPF. 
In our study, the bronchial stump was closed 
manually in 39% of cases using absorbable suture 
because it is not associated with late suture 
granuloma formation [24]. Stapler closure was 
performed in 61% of cases. One patient developed 
BPF, which could be attributed to predisposing 
factors such as right-side surgery, history of 
tuberculosis, and preoperative empyema. In our 
study, the rate of postoperative empyema and BPF 
was 3.6%. This low rate compared to others may 
be attributed to the strict preoperative 
preparation of the patients and the routine use of 
stump reinforcement with adjacent viable tissues.  
Additionally, we had only 2 cases of preoperative 
empyema, and we excluded emergency cases 
from the study. Pneumonectomy for destroyed 
lung leads to better oxygenation by preventing 
systemic-pulmonary shunting [25]. We achieved 
satisfactory outcomes in all patients except one 
who developed postoperative empyema and BPF 
in the early postoperative period.  
The patient characteristics in Egypt and other 
developing countries are different from other 
developed countries. In a study by Klapper and 
colleagues for the outcome of pneumonectomy 
for the benign disease, they had more males and 
right-sided disease. A third of their cases were 
completion pneumonectomy. They did not report 
cases with neglected FBs and no TB cases [26]. 
These findings are different from the results 
reported in our study and other similar studies 
from developing countries [27]. Klapper and 
colleagues reported a 29% mortality rate for the 
entire cohort; in our study, the mortality rate was 
3.6 %. This could be attributed to the enrollment 
of elective cases only. In Klapper's research, 83% 
of deaths were operated on an emergent or 
urgent basis with associated serious 
comorbidities.  They found that mortality was 
reduced to less than 10% after the exclusion of 
the emergency cases [26], which is following our 
results and other reports.  [28] 
Some of the best results reported for benign 
pneumonectomy have come from areas where 
pulmonary tuberculosis is endemic, and thus 
experience with the operative management of 
these patients is vast. Conlan and colleagues 
reported the results of benign elective 
pneumonectomy in 124 patients over 14 years in 
South Africa, demonstrating hospital mortality of 
only 2.4% [9]. Likewise, Blythe reported a 1.2% 
mortality among 155 elective benign 
pneumonectomies [18]. 
In the for mentioned studies, the authors 
practiced a comprehensive approach for 
recognizing these patients early on and improving 
their overall performance status, thus avoiding the 
outcome and consequences of urgent operations. 
This strategy and results were in accordance with 





our results. Consequently, it is obvious that, for 
patients requiring benign pneumonectomy, the 
most significant mortality predictor is the urgency 
of surgery. 
Some authors have suggested that patients 
undergoing completion pneumonectomy for 
benign conditions were more likely to have a 
more operative risk [29, 30]. On the contrary, 
other reports did not find higher mortality in the 
completion pneumonectomy subset [26]. No 
complications were reported in completion 
pneumonectomy in our study, but completion 
pneumonectomy was reported in 2 cases only. 
Operative time > 4 hours, Old age (>70 y), 
intraoperative blood loss > 1 liter, and 
preoperative steroid use were reported to 
increase the risk of complications associated with 
benign pneumonectomy [22]. In our study, the 
increased operative time and blood loss were 
more in patients who had extrapleural 
pneumonectomy. 
Three patients out of 7 who developed 
postoperative complications had extrapleural 
pneumonectomy, and one mortality occurred in 
this group. Li and colleagues reported two 
intraoperative deaths during pneumonectomy for 
inflammatory lung disease, one from 
uncontrollable bleeding, and the other form 
contralateral dissemination [14]. In our study, no 
intraoperative mortality was reported. 
The reported postoperative morbidity and 
mortality rates in our study were 25% and 3.6 % 
(n = 1), respectively. These results were consistent 
with the published data (range, 11.9 –23% and 0–
5.9, respectively) [13, 14, 19, 20]. Other studies 
reported postoperative mortality in destroyed 
lung diseases between 4 and 8.5% [21].   
Limitations: 
This study's limitations include its 
retrospective nature and the small sample size, 
making a barrier against the accurate estimation 
of the different variables' effect on the outcome. 
Conclusion 
Pneumonectomy for benign lung disease is a 
challenging procedure. Destroyed lung due to TB 
and bronchiectasis are the most common 
indications. The outcome could be improved with 
careful patient selection, appropriate 
preoperative preparation, meticulous operative 
techniques, and high postoperative care 
standards. 
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